13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001773206
Total reported value
$2.5B
$2.5B
74 檔
20.9%
The Q3 2025 SEC filing reveals that Integral Health Asset Management, LLC held a total portfolio value of $2.5B, covering 74 public equity positions.
Integral Health Asset Management, LLC executed strategic sector rebalancing during Q3 2025, establishing 30 new positions while fully exiting 36 holdings and trimming 11 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | INSM | Insmed Inc | Stock-Healthcare | 16.56% | -4.99% | +6.25% | |
| 2 | CYTK | Cytokinetics Inc | Stock-Healthcare | 7.99% | -2.82% | +43.33% | |
| 3 | THC | Tenet Healthcare CORP | Stock-Healthcare | 4.12% | +1.22% | NEW | |
| 4 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 3.85% | -1.14% | -44.44% | |
| 5 | VERA | Vera Therapeutics Inc | Stock-Other | 3.34% | -0.11% | +47.83% | |
| 6 | QURE | uniQure N.V. | Stock-Other | 2.37% | +0.94% | -55.56% | |
| 7 | BTSG | Brightspring Health Services | Stock-Other | 2.30% | -1.03% | -8.00% | |
| 8 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.98% | -0.13% | -45.45% | |
| 9 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 1.92% | — | — | |
| 10 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 1.90% | -2.15% | — | |
| 11 | ALHC | Alignment Healthcare Inc | Stock-Other | 1.89% | -0.29% | +300.00% | |
| 12 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.85% | — | +9.09% | |
| 13 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 1.74% | -0.59% | — | |
| 14 | EHC | Encompass Health CORP | Stock-Healthcare | 1.72% | — | -37.50% | |
| 15 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 1.65% | +0.80% | +50.00% | |
| 16 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 1.56% | — | +50.00% | |
| 17 | RDNT | Radnet Inc | Stock-Healthcare | 1.55% | — | -25.00% | |
| 18 | RYTM | Rhythm Pharmaceuticals Inc | Stock-Other | 1.50% | -0.09% | +83.33% | |
| 19 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 1.50% | +1.70% | NEW | |
| 20 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 1.42% | +0.05% | — | |
| 21 | CAH | Cardinal Health Inc | Stock-Healthcare | 1.38% | +0.09% | -7.14% | |
| 22 | RZLT | Rezolute Inc | Stock-Other | 1.27% | -0.19% | +11.11% | |
| 23 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 1.26% | +0.53% | +23.08% | |
| 24 | DGX | Quest Diagnostics Inc | Stock-Healthcare | 1.10% | +1.11% | -43.33% | |
| 25 | ELV | Elevance Health Inc | Stock-Healthcare | 1.09% | -0.29% | -16.67% | |
| 26 | ELAN | Elanco Animal Health Inc | Stock-Healthcare | 1.09% | -0.63% | EXIT | |
| 27 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 1.05% | +1.58% | — | |
| 28 | LLY | Eli Lilly & Co | Stock-Healthcare | 1.03% | +0.05% | -20.00% | |
| 29 | CVS | Cvs Health CORP | Stock-Healthcare | 1.02% | +3.97% | -20.00% | |
| 30 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 1.01% | -0.67% | EXIT | |
| 31 | MDT | Medtronic plc | Stock-Healthcare | 0.97% | +0.62% | NEW | |
| 32 | CNC | Centene CORP | Stock-Healthcare | 0.97% | -0.26% | — | |
| 33 | DOCS | Doximity Inc-class A | Stock-Healthcare | 0.89% | — | — | |
| 34 | PFE | Pfizer Inc | Stock-Healthcare | 0.86% | — | -28.57% | |
| 35 | PEN | Penumbra Inc | Stock-Healthcare | 0.86% | — | +25.00% | |
| 36 | ACLXGBX | Arcellx Inc | Stock-Other | 0.83% | — | — | |
| 37 | ASND | Ascendis Pharma A/S | Stock-Other | 0.81% | -1.26% | EXIT | |
| 38 | FMS | Fresenius Medical Care-adr | Stock-Other | 0.80% | -0.84% | EXIT | |
| 39 | MCK | Mckesson CORP | Stock-Healthcare | 0.78% | — | +50.00% | |
| 40 | A | Agilent Technologies Inc | Stock-Healthcare | 0.78% | — | +80.00% | |
| 41 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 0.77% | +0.15% | +25.00% | |
| 42 | NVST | Envista Holdings CORP | Stock-Healthcare | 0.76% | +0.20% | — | |
| 43 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.76% | -0.77% | EXIT | |
| 44 | IRTC | Irhythm Holdings Inc | Stock-Healthcare | 0.76% | +0.42% | NEW | |
| 45 | EXK | Exact Sciences CORP | Stock-Materials | 0.74% | — | +100.00% | |
| 46 | UPB | Upstream Bio Inc | Stock-Other | 0.73% | — | — | |
| 47 | ORIC | Oric Pharmaceuticals Inc | Stock-Other | 0.73% | -0.04% | -28.00% | |
| 48 | RGNX | Regenxbio Inc | Stock-Other | 0.72% | -0.22% | +57.14% | |
| 49 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 0.70% | — | +450.00% | |
| 50 | DYN | Dyne Therapeutics Inc | Stock-Other | 0.68% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | INSM | Insmed Inc | +4% | +6.25% | Add |
| 2 | CYTK | Cytokinetics Inc | +3.3% | +43.33% | Add |
| 3 | ALHC | Alignment Healthcare Inc | +1.5% | +300.00% | Add |
| 4 | RZLT | Rezolute Inc | +1.1% | +11.11% | Add |
| 5 | QURE | uniQure N.V. | +1% | -55.56% | Trim |
| 6 | BTSG | Brightspring Health Services | +0.8% | -8.00% | Add |
| 7 | OSCR | Oscar Health Inc - Class A | +0.4% | +450.00% | Add |
| 8 | ALNY | Alnylam Pharmaceuticals Inc | +0.4% | +9.09% | Add |
| 9 | VERA | Vera Therapeutics Inc | +0.4% | +47.83% | Add |
| 10 | RVMD | Revolution Medicines Inc | +0.3% | +23.08% | Add |
| 11 | ARWR | Arrowhead Pharmaceuticals In | +0.3% | — | Add |
| 12 | 430 | Terns Pharmaceuticals Inc | +0.3% | +35.71% | Add |
| 13 | RDNT | Radnet Inc | +0.2% | -25.00% | Add |
| 14 | BHVN | Biohaven Ltd. | +0.2% | +116.67% | Add |
| 15 | THC | Tenet Healthcare CORP | +0.2% | +9.09% | Add |
| 16 | DYN | Dyne Therapeutics Inc | +0.2% | — | Add |
| 17 | ROIV | Roivant Sciences Ltd. | +0.1% | +25.00% | Add |
| 18 | SANA | Sana Biotechnology Inc | +0.1% | +33.33% | Unchanged |
| 19 | EW | Edwards Lifesciences CORP | +0.1% | — | Add |
| 20 | PFE | Pfizer Inc | +0.1% | -28.57% | Add |
| 21 | RGNX | Regenxbio Inc | 0% | +57.14% | Add |
| 22 | IQV | Iqvia Holdings Inc | 0% | — | Add |
| 23 | ANRO | Alto Neuroscience Inc | 0% | — | Unchanged |
| 24 | TENX | Tenax Therapeutics Inc | 0% | — | Unchanged |
| 25 | MLYS | Mineralys Therapeutics Inc | 0% | -44.44% | Trim |
| 26 | TARS | Tarsus Pharmaceuticals Inc | -0.1% | +25.00% | Add |
| 27 | MCK | Mckesson CORP | -0.1% | +50.00% | Add |
| 28 | NRIX | Nurix Therapeutics Inc | -0.1% | +12.90% | Add |
| 29 | PEN | Penumbra Inc | -0.1% | +25.00% | Add |
| 30 | SRRK | Scholar Rock Holding CORP | -0.2% | — | Trim |
| 31 | TARA | Protara Therapeutic Inc | -0.2% | — | Unchanged |
| 32 | ACHC | Acadia Healthcare Co Inc | -0.3% | -25.00% | Add |
| 33 | NBIX | Neurocrine Biosciences Inc | -0.4% | — | Unchanged |
| 34 | CVS | Cvs Health CORP | -0.4% | -20.00% | Unchanged |
| 35 | INSP | Inspire Medical Systems Inc | -0.5% | +71.43% | Add |
| 36 | ACLXGBX | Arcellx Inc | -0.6% | — | Trim |
| 37 | EWTX | Edgewise Therapeutics Inc | -0.6% | +50.00% | Add |
| 38 | ASND | Ascendis Pharma A/S | -0.9% | — | Trim |
| 39 | FMS | Fresenius Medical Care-adr | -1% | -40.00% | Trim |
| 40 | EHC | Encompass Health CORP | -1.2% | -37.50% | Trim |
| 41 | NVS | Novartis Ag-sponsored Adr | -1.2% | — | Trim |
| 42 | MDT | Medtronic plc | -1.9% | -25.00% | Trim |
| 43 | ELV | Elevance Health Inc | -1.9% | -16.67% | Trim |
| 44 | BSX | Boston Scientific CORP | -5% | -45.45% | Trim |
| 45 | NAMS | NewAmsterdam Pharma Company N.V. | — | NEW | New buy |
| 46 | REGN | Regeneron Pharmaceuticals | — | NEW | New buy |
| 47 | AZNN | Astrazeneca Plc-spons Adr | — | NEW | New buy |
| 48 | RYTM | Rhythm Pharmaceuticals Inc | — | NEW | New buy |
| 49 | NVO | Novo-nordisk A/s-spons Adr | — | NEW | New buy |
| 50 | CAH | Cardinal Health Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Integral Health Asset Management, LLC reported a total U.S. public equity portfolio value of $2.5B across 74 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including INSM, CYTK, THC) accounted for 20.9% of total reported equity market value during Q3 2025.
Top New Position Initiated
NAMS
市值: $28.4M
Top Position Liquidated / Trimmed
GILD
前期市值: $19.6M
During Q3 2025, Integral Health Asset Management, LLC's top holdings by market value included INSM (16.6%)、CYTK (8.0%)、THC (4.1%). The largest single position, INSM, represented 16.6% of total portfolio value.
In Q3 2025, Integral Health Asset Management, LLC made 104 total portfolio adjustments, initiating 30 new buys, adding to 27 positions, trimming 11 holdings, and fully liquidating 36 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.